iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Queen's University · European Organisation for Research and Treatment of Cancer · +15 more institutions
Indexed incrossref
Abstract
No abstract available for this paper.
Citation impact
2,375
total citations
- FWCI
- 86.69
- Percentile
- 100%
- References
- 39
Citations per year
Authors
18- LSLesley SeymourCorresponding
Queen's University
- JBJan Bogaerts
European Organisation for Research and Treatment of Cancer
- APAndrea Perrone
Merck & Co., Inc., Rahway, NJ, USA (United States)
- RFRobert Ford
Clinical Research Consulting
- LHLawrence H. Schwartz
Columbia University Irving Medical Center, NewYork–Presbyterian Hospital
Topics & keywords
Topics
Keywords
- Guideline
- Clinical trial
- Medicine
- Medical physics
- Response Evaluation Criteria in Solid Tumors
- Immunotherapy
- Cancer
- Intensive care medicine
No related works found for this paper.